China approves Blackstone, TPG acquisition of medtech firm Hologic

China ‍has approved private equity firms Blackstone and ⁠TPG's acquisition of medical diagnostics firm Hologic, according to a ‌list of ‌deal approvals from the country's ‌market regulator released on Tuesday.

Hologic, which develops and distributes medical imaging and diagnostic products for women's ​healthcare, has ​manufacturing operations and a partnership ‌in ‍China.

The State Administration ‍for Market Regulation did not detail whether ‌the approval was for the acquisition of specific Hologic China-based units.


The regulator has jurisdiction over foreign companies with substantial ‍business or sales in China.

Blackstone and ‍TPG announced ⁠in ⁠October they would take Hologic private for $18.3 billion including debt, in the largest medical devices deal in almost two decades.